Skip to main content
Muller & Phipps (India) Ltd. logo

Muller & Phipps (India) Ltd. — Investor Relations & Filings

Ticker · 501477 ISIN · INE003F01015 BSE.NS Wholesale and retail trade
Filings indexed 248 across all filing types
Latest filing 2024-02-08 Regulatory Filings
Country IN India
Listing BSE.NS 501477

About Muller & Phipps (India) Ltd.

https://mulphico.swayantra.com/

Muller & Phipps (India) Ltd. focuses on the marketing and distribution of consumer healthcare, personal care, and home care products. The company manages a portfolio of established brands, including Sloan's Liniment and Nixoderm, specializing in over-the-counter pharmaceuticals and medicated skin care solutions. Its core operations involve managing complex supply chains and logistics networks to facilitate product placement across retail and pharmaceutical channels. The organization provides integrated brand management services, including sales strategy and distribution logistics, to ensure consistent market availability. By utilizing an extensive infrastructure and historical expertise in brand representation, the company serves as a key intermediary between manufacturing entities and the end-consumer market, maintaining a focus on quality and accessibility in its product range.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that the Board of Directors ....
Regulatory Filings
2024-02-08 English
MULLER & PHIPPS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 ,inter alia, to consider and approve Dear Sir, Pursuant ....
Regulatory Filings Classification · 95% confidence The document is a notice from Muller and Phipps India Limited informing about a scheduled Board Meeting on February 8, 2024. The purpose of the meeting includes considering and taking on record the unaudited financial results for the quarter and nine months ended December 31, 2023. The document is short (1022 characters) and serves as an announcement of an upcoming board meeting and financial results consideration, not the financial report itself. It references Regulation 29 and 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, which govern disclosures related to board meetings and financial results announcements. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the board meeting and financial results consideration, not the actual financial report or earnings release.
2024-01-31 English
We herewith enclose a certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulation 2018, for the quarter ended 31-12-2023, received from Link Intime India Private Limited ....
Regulatory Filings
2024-01-11 English
Loss of share certificates
Regulatory Filings
2024-01-03 English
In terms of Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulation 2015, the exchange is hereby informed that the trading restriction period will commence from January ....
Regulatory Filings
2023-12-29 English
Details of Loss of certificate
Regulatory Filings
2023-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.